Belite Bio BLTE
NASDAQ BLTE
$153.43 -1.02 (-0.66%)
As of: Oct 21, 2026 · 3:59 PM EDT

Belite Bio (BLTE) Current Leases (2022 - 2025)

Updated

Analysis

Belite Bio (BLTE) Current Leases (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Belite Bio 5.16 Bn 5.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 241,000.00
Dec 31, 2024 276,000.00
Dec 31, 2023 308,000.00
Dec 31, 2022 198,000.00
API Access

Belite Bio Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=BLTE&period=max&api_key=YOUR_API_KEY